衞星化學(002648.SZ):已組建了高水平研發團隊,提前佈局突破“卡脖子”技術難題
格隆匯7月16日丨衞星化學(002648.SZ)在互動平台表示,目前,國內行業“低端過剩,高端緊缺”的結構性問題愈發突出。據查,高端聚烯烴自給率僅為65%。其中,高端聚乙烯、POE等產品高度依賴進口。高端聚乙烯材料有較好的經濟效益,技術壁壘極高,高性能催化劑、聚合工藝、共聚單體等技術難點仍是阻礙高端聚烯烴材料國產化率提升的關鍵因素。公司已組建了高水平研發團隊,提前佈局突破“卡脖子”技術難題,加速工業化裝置落地。公司將繼續牢牢把握市場機遇,精準滿足下游市場日益增長的多樣化需求,充分發揮先發優勢,推動高端聚烯烴材料的國產化進程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.